4
Changes in Ownership
Krystal Biotech, Inc. Filed Acc 0001209191-20-030562
President and CEO sold 50,000 shares at an average $58.14 ($2,906,907)
From the SEC's structured data for this filing
Trades in this filing
Krishnan Krish S · President and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-15 | Sale : show line 1 in the form | −3,842 | $57.43 | $220,639 | 1,932,620 | D |
| 2020-05-15 | Sale : show line 2 in the form | −12,445 | $58.09 | $722,873 | 1,920,175 | D |
| 2020-05-15 | Sale : show line 3 in the form | −10,552 | $59.03 | $622,874 | 1,909,623 | D |
| 2020-05-18 | Sale : show line 4 in the form | −2,900 | $55.99 | $162,357 | 1,906,723 | D |
| 2020-05-18 | Sale : show line 5 in the form | −6,784 | $56.84 | $385,589 | 1,899,939 | D |
| 2020-05-18 | Sale : show line 6 in the form | −5,371 | $57.63 | $309,532 | 1,894,568 | D |
| 2020-05-18 | Sale : show line 7 in the form | −1,805 | $59.11 | $106,699 | 1,892,763 | D |
| 2020-05-18 | Sale : show line 8 in the form | −6,301 | $59.73 | $376,345 | 1,886,462 | D |
| Open-market sales · 50,000 sh · avg $58.14 · $2,906,907 | ||||||
Loading xslF345X03/doc4.xml…